A Randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2014
At a glance
- Drugs Gemigliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors LG Life Sciences
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 29 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Sep 2011 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History